Assenagon Asset Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-39,180
| Closed | -$597K | – | 1416 |
|
|
2024
Q2 | $597K | Sell |
39,180
-551
| -1% | -$8.39K | ﹤0.01% | 1177 |
|
|
2024
Q1 | $750K | Sell |
39,731
-7,522
| -16% | -$142K | ﹤0.01% | 1091 |
|
|
2023
Q4 | $903K | Buy |
+47,253
| New | +$903K | ﹤0.01% | 1087 |
|
|
2023
Q1 | – | Sell |
-115,651
| Closed | -$2.39M | – | 1443 |
|
|
2022
Q4 | $2.39M | Buy |
+115,651
| New | +$2.39M | 0.01% | 726 |
|
|
2021
Q2 | – | Sell |
-11,278
| Closed | -$317K | – | 1331 |
|
|
2021
Q1 | $317K | Sell |
11,278
-30,396
| -73% | -$854K | ﹤0.01% | 1055 |
|
|
2020
Q4 | $1.08M | Sell |
41,674
-276,613
| -87% | -$7.18M | ﹤0.01% | 684 |
|
|
2020
Q3 | $5.46M | Buy |
318,287
+172,135
| +118% | +$2.95M | 0.03% | 278 |
|
|
2020
Q2 | $3.62M | Buy |
+146,152
| New | +$3.62M | 0.02% | 390 |
|